Comparison of 5‐tiered and 6‐tiered diagnostic systems for the reporting of thyroid cytopathology
- 13 October 2011
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 120 (2), 117-125
- https://doi.org/10.1002/cncy.20195
Abstract
BACKGROUND: At present, thyroid fine‐needle aspiration (FNA) specimens are diagnosed using a tiered classification scheme, with the most popular of these being the 5‐tiered and 6‐tiered systems. In this study, the authors present their institutional experiences using these 2 different systems and evaluate their efficacy based on the surgical follow‐up. METHODS: Thyroid FNA specimens and their corresponding surgical resection specimens were collected between 2007 and 2009. The following diagnostic categories are used in both systems: unsatisfactory/nondiagnostic, benign, follicular neoplasm/suspicious for follicular neoplasm, suspicious for malignancy, and malignant. An additional category termed atypia of undetermined significance/follicular lesion of undetermined significance was used for atypical cases in the 6‐tiered system. Statistical analysis was performed by comparing the different diagnostic categories. RESULTS: The case cohort included a total of 7686 thyroid FNA specimens representing 3962 nodules and 3724 nodules, respectively, in the 5‐tiered and 6‐tiered systems. Negative predictive values for the benign categories (96.9% vs 97.5%; P = 1) and positive predictive values for both the follicular neoplasm categories (26.5% vs 32.1%; P = .2531) and the malignant categories (99.1% vs 99.4%; P = 1) were similar. The most significant differences between the 5‐tiered and 6‐tiered systems were the percentage of cases classified as benign (83.9% vs 55.4%; P < .0001) and as follicular neoplasms (4.6% vs 23.8%; P < .0001). It is interesting to note that fewer patients were referred for surgery in the 5‐tiered system compared with the 6‐tiered one (9.1% vs 36.5%; P < .0001). CONCLUSIONS: Use of either the 5‐tiered or 6‐tiered reporting systems for thyroid FNA specimens can potentially affect the clinical management of patients with thyroid nodules. Cancer (Cancer Cytopathol) 2012. © 2011 American Cancer Society.Keywords
This publication has 32 references indexed in Scilit:
- Fine-Needle Aspiration in the Work-Up of Thyroid NodulesOtolaryngologic Clinics of North America, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Thyroid Fine-Needle Aspiration Biopsy: Variability in ReportingThyroid®, 2009
- An updated audit of fine needle aspiration cytology procedure of solitary thyroid noduleDiagnostic Cytopathology, 2008
- Validation of a Five-Tier Cytodiagnostic System for Thyroid Fine Needle Aspiration Biopsies Using Cytohistologic CorrelationThyroid®, 2006
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines TaskforceThyroid®, 2006
- American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid NodulesEndocrine Practice, 2006
- Expanding Role of Fine‐needle Aspiration Cytology in Thyroid Diagnosis and ManagementWorld Journal of Surgery, 2000
- Guidelines of The Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules: The Papanicolaou Society of Cytopathology Task Force on Standards of PracticeDiagnostic Cytopathology, 1996
- Management of a Solitary Thyroid NoduleThe New England Journal of Medicine, 1993